Pharmafile Logo
Pharmafocus logo
Advanced Search

developing world

Showing 7 posts of 7 posts found.

GSK and Merck cut vaccine prices

June 6, 2011
Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines

GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …

News

UNICEF highlights price differences for vaccines

June 2, 2011
Sales and Marketing Unicef, developing world, vaccines

A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …

News

GSK tops access to medicines ranking

June 21, 2010
Sales and Marketing GlaxoSmithKline, developing world, medicines access

GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …

News
Vaccination

Cheaper vaccines for developing countries

March 24, 2010
Vaccine, developing world, vaccines

GlaxoSmithKline and Pfizer have signed a deal to supply anti-pneumococcal drugs to developing countries at steeply discounted prices. GSK will …

News

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010
Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …

News

Gates’ $10 billion vaccines pledge to cut child mortality

February 1, 2010
Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines

Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …

News

New market access approach could save poorer countries millions

December 1, 2009
Sales and Marketing HIV, access, developing world

  An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025